244 studies found for:    Mesothelioma
Show Display Options
Rank Status Study
1 Recruiting Do Your Genes Put You at a Higher Risk of Developing Mesothelioma
Condition: Mesothelioma
Intervention:
2 Active, not recruiting Psychosocial Needs and Exploration of Online Support for Patients With Mesothelioma
Condition: Mesothelioma
Intervention: Behavioral: Questionnaires & online virtual support group
3 Active, not recruiting
Has Results
Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy
Conditions: Pleural Mesothelioma;   Peritoneal Mesothelioma
Intervention: Drug: IMC-A12
4 Completed Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity
Condition: Malignant Pleural Mesothelioma
Intervention: Drug: everolimus
5 Recruiting Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Condition: Mesothelioma
Intervention:
6 Recruiting Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma.
Condition: Malignant Pleural Mesothelioma
Intervention: Biological: HSV1716 Intra-pleural delivery
7 Active, not recruiting Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma
Condition: Mesothelioma
Interventions: Drug: Cisplatin;   Drug: Imatinib Mesylate;   Drug: Pemetrexed
8 Recruiting Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos
Conditions: Mesothelioma;   Lung Cancer
Intervention:
9 Recruiting Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma
Conditions: Mesothelioma;   Pleural Mesothelioma
Interventions: Drug: Pemetrexed;   Drug: Cisplatin
10 Completed Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma
Condition: Mesothelioma
Interventions: Drug: Erlotinib;   Drug: Bevacizumab
11 Recruiting Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Interventions: Drug: defactinib (VS-6063);   Drug: Placebo
12 Completed
Has Results
Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: dasatinib
13 Active, not recruiting SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma
Condition: Mesothelioma
Interventions: Drug: SS1P;   Drug: Pemetrexed;   Drug: Cisplatin
14 Completed An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma
Condition: Mesothelioma
Intervention: Drug: ZD1839
15 Recruiting Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma
Conditions: Recurrent Malignant Mesothelioma;   Stage IA Malignant Mesothelioma;   Stage IB Malignant Mesothelioma;   Stage II Malignant Mesothelioma;   Stage III Malignant Mesothelioma;   Stage IV Malignant Mesothelioma
Interventions: Biological: oncolytic measles virus encoding thyroidal sodium iodide symporter;   Other: laboratory biomarker analysis;   Procedure: single photon emission computed tomography;   Procedure: computed tomography
16 Completed Serum Biomarkers in Diagnosis of Mesothelioma
Condition: Mesothelioma
Intervention: Biological: Mesothelin, hyaluronan, osteopontin, syndecan-1
17 Completed SU5416 in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: semaxanib
18 Completed Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Interventions: Drug: pemetrexed;   Drug: cisplatin
19 Active, not recruiting Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Interventions: Procedure: Extrapleural pneumonectomy (EPP), Pleurectomy/Decortication;   Drug: cisplatin;   Drug: gemcitabine;   Drug: amifostine;   Drug: sodium thiosulfate
20 Unknown  Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: cisplatin;   Drug: mitomycin C;   Drug: vinblastine sulfate;   Drug: vinorelbine tartrate

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years